Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Moderna Inc. buy Barclays PLC

Start price
€62.07
16.09.24 / 50%
Target price
€112.33
16.09.25
Performance (%)
4.37%
Price
€64.78
17.09.24
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 4.37%. This prediction currently runs until 16.09.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w
Moderna Inc. 4.37%
iShares Core DAX® 1.887%
iShares Nasdaq 100 2.316%
iShares Nikkei 225® 1.134%
iShares S&P 500 1.821%

Comments by Barclays_PLC for this prediction

In the thread Moderna Inc. diskutieren
Prediction Buy
Perf. (%) 4.37%
Target price 112.325
Change
Ends at 16.09.25

Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Barclays PLC from $155.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for MRNA provided by MarketBeat

Stopped prediction by Barclays_PLC for Moderna Inc.

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€81.21
02.08.24
€141.86
02.08.25
-20.23%
17.09.24